Effect of 3-aminobenzamide on antigenic variation of Trypanosoma brucei

African trypanosomes, like Trypanosoma brucei, depend on antigenic variation to evade the immune response of the vertebrate host. An antigenic switch corresponds to the activation of a variable surface glycoprotein (VSG) gene from a large silent repertoire. Most switches require the duplicative tran...

Full description

Saved in:
Bibliographic Details
Published inBiochemical pharmacology Vol. 34; no. 23; p. 4151
Main Authors Cornelissen, A W, Michels, P A, Borst, P, Spanjer, W, Versluijs-Broers, J A, Van der Meer, C, Farzaneh, F, Shall, S
Format Journal Article
LanguageEnglish
Published England 01.12.1985
Subjects
Online AccessGet more information

Cover

Loading…
Abstract African trypanosomes, like Trypanosoma brucei, depend on antigenic variation to evade the immune response of the vertebrate host. An antigenic switch corresponds to the activation of a variable surface glycoprotein (VSG) gene from a large silent repertoire. Most switches require the duplicative transposition of a VSG gene, which involves strand breaks in DNA and subsequent repair. The nuclear enzyme adenosine-diphosphoribosyl transferase (ADPRT), which is dependent on the presence of DNA strand breaks for its activity, might be involved in this process because it has a regulatory role in DNA repair in all eukaryotic cells studied so far. In previous work, the presence of ADPRT activity was demonstrated in T. brucei. Moreover, it was also shown in isolated trypanosomes the ADPRT activity, which is stimulated by the induction of DNA strand breaks, could be blocked by the competitive inhibitor 3-aminobenzamide. Here we report experiments using rats which were infected with small numbers of T. brucei expressing VSG gene 118. After two days, the rats were coupled to a continuous intraperitoneal infusion system administrating 3-aminobenzamide in 0.9% NaCl (81.4 mM) at a rate of 0.65 ml/hr/rat for a period of up to five days. Control rats received only a 0.9% NaCl infusion. At days 1, 3 and 5, 250 microliters blood was obtained from a tail artery. Plasma 3-aminobenzamide was determined using a new high performance liquid chromatography method, developed for these experiments. In most rats the plasma concentrations were maintained between 0.8 and 1.2 mM. The rate of antigenic switching was determined by quantitating the fraction of trypanosomes that had lost their VSG 118 coat, using antibody against VSG 118 and a limiting dilution in mice. The average switching rate found was 2.0 X 10(-6) in controls and 1.3 X 10(-7) in drug-treated rats (15-fold reduction). This suggests that ADPRT is required for completing most antigenic switching events. We discuss the possibility that drug-resistant switching only involves non-duplicative VSG gene activation.
AbstractList African trypanosomes, like Trypanosoma brucei, depend on antigenic variation to evade the immune response of the vertebrate host. An antigenic switch corresponds to the activation of a variable surface glycoprotein (VSG) gene from a large silent repertoire. Most switches require the duplicative transposition of a VSG gene, which involves strand breaks in DNA and subsequent repair. The nuclear enzyme adenosine-diphosphoribosyl transferase (ADPRT), which is dependent on the presence of DNA strand breaks for its activity, might be involved in this process because it has a regulatory role in DNA repair in all eukaryotic cells studied so far. In previous work, the presence of ADPRT activity was demonstrated in T. brucei. Moreover, it was also shown in isolated trypanosomes the ADPRT activity, which is stimulated by the induction of DNA strand breaks, could be blocked by the competitive inhibitor 3-aminobenzamide. Here we report experiments using rats which were infected with small numbers of T. brucei expressing VSG gene 118. After two days, the rats were coupled to a continuous intraperitoneal infusion system administrating 3-aminobenzamide in 0.9% NaCl (81.4 mM) at a rate of 0.65 ml/hr/rat for a period of up to five days. Control rats received only a 0.9% NaCl infusion. At days 1, 3 and 5, 250 microliters blood was obtained from a tail artery. Plasma 3-aminobenzamide was determined using a new high performance liquid chromatography method, developed for these experiments. In most rats the plasma concentrations were maintained between 0.8 and 1.2 mM. The rate of antigenic switching was determined by quantitating the fraction of trypanosomes that had lost their VSG 118 coat, using antibody against VSG 118 and a limiting dilution in mice. The average switching rate found was 2.0 X 10(-6) in controls and 1.3 X 10(-7) in drug-treated rats (15-fold reduction). This suggests that ADPRT is required for completing most antigenic switching events. We discuss the possibility that drug-resistant switching only involves non-duplicative VSG gene activation.
Author Shall, S
Michels, P A
Versluijs-Broers, J A
Van der Meer, C
Spanjer, W
Borst, P
Farzaneh, F
Cornelissen, A W
Author_xml – sequence: 1
  givenname: A W
  surname: Cornelissen
  fullname: Cornelissen, A W
– sequence: 2
  givenname: P A
  surname: Michels
  fullname: Michels, P A
– sequence: 3
  givenname: P
  surname: Borst
  fullname: Borst, P
– sequence: 4
  givenname: W
  surname: Spanjer
  fullname: Spanjer, W
– sequence: 5
  givenname: J A
  surname: Versluijs-Broers
  fullname: Versluijs-Broers, J A
– sequence: 6
  givenname: C
  surname: Van der Meer
  fullname: Van der Meer, C
– sequence: 7
  givenname: F
  surname: Farzaneh
  fullname: Farzaneh, F
– sequence: 8
  givenname: S
  surname: Shall
  fullname: Shall, S
BackLink https://www.ncbi.nlm.nih.gov/pubmed/2998400$$D View this record in MEDLINE/PubMed
BookMark eNo9j09LAzEUxHOo1Lb6DRT2qIfoS_ZP3h6ltFUoeKnn8pJ9kYiblN2tUD-9KxZPM_NjGJi5mMQUWYgbBQ8KVPUIAJXUdanvsLyvQQPKYiJm__hSzPv-4zdipaZiqusaC4CZ2Ky8ZzdkyWe5pDbEZDl-j6bhLMWM4hDeOQaXfVEXaAgjG6u77nSgmPrUUma7o-NwJS48ffZ8fdaFeFuvdstnuX3dvCyfttIVygxS2xINKmvQWfBsiZ2vckWMqjCE2FgD5JVWJebOEGlfeK5yaIhrUwLqhbj92z0cbcvN_tCFlrrT_nxI_wC95k4Z
CitedBy_id crossref_primary_10_1016_0014_4827_87_90385_5
crossref_primary_10_1016_0163_7258_85_90026_9
crossref_primary_10_1016_j_actatropica_2020_105499
crossref_primary_10_1016_0022_2836_87_90717_0
crossref_primary_10_1016_0014_4894_88_90090_2
crossref_primary_10_1016_0305_0491_90_90051_T
crossref_primary_10_1016_0378_1119_92_90557_6
crossref_primary_10_1080_09553008714551431
crossref_primary_10_1016_0006_2952_87_90065_7
crossref_primary_10_1016_0167_8140_89_90083_2
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1016/0006-2952(85)90208-4
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Chemistry
Pharmacy, Therapeutics, & Pharmacology
ExternalDocumentID 2998400
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-~X
.55
.GJ
.HR
.~1
0R~
1RT
1~5
23N
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
6J9
7-5
8P~
9JM
AABNK
AACTN
AAEDW
AALRI
AAOAW
AAQFI
AAQXK
AAXUO
ABFNM
ABFRF
ABJNI
ABLJU
ABMAC
ACGFO
ACGFS
ACIUM
ACNCT
ACRLP
ADMUD
AEFWE
AENEX
AFFNX
AFTJW
AGUBO
AHHHB
AI.
AIKHN
AITUG
ALMA_UNASSIGNED_HOLDINGS
ASPBG
AVWKF
AZFZN
BLXMC
CGR
CS3
CUY
CVF
DU5
EBS
ECM
EIF
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
G-2
G-Q
HMT
HVGLF
HZ~
IH2
J1W
K-O
L7B
M34
N9A
NPM
O9-
OAUVE
P2P
Q38
R2-
ROL
SDF
SDG
SDP
SES
SPCBC
SPT
T5K
TWZ
VH1
WH7
WUQ
X7M
ZGI
ZXP
~G-
ID FETCH-LOGICAL-c417t-2b58781b78cb0febaecf631ae8147a88db70af121583c7aa2f4fe630dae975082
ISSN 0006-2952
IngestDate Sat Sep 28 08:37:04 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 23
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c417t-2b58781b78cb0febaecf631ae8147a88db70af121583c7aa2f4fe630dae975082
PMID 2998400
ParticipantIDs pubmed_primary_2998400
PublicationCentury 1900
PublicationDate 1985-12-01
PublicationDateYYYYMMDD 1985-12-01
PublicationDate_xml – month: 12
  year: 1985
  text: 1985-12-01
  day: 01
PublicationDecade 1980
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Biochemical pharmacology
PublicationTitleAlternate Biochem Pharmacol
PublicationYear 1985
SSID ssj0006861
Score 1.3807371
Snippet African trypanosomes, like Trypanosoma brucei, depend on antigenic variation to evade the immune response of the vertebrate host. An antigenic switch...
SourceID pubmed
SourceType Index Database
StartPage 4151
SubjectTerms Animals
Antigens, Protozoan
Benzamides - blood
Benzamides - pharmacology
DNA Repair
Female
Glycoproteins - genetics
Guinea Pigs
Mice
Nucleotidyltransferases - physiology
Poly(ADP-ribose) Polymerases
Rats
Trypanosoma brucei brucei - drug effects
Trypanosoma brucei brucei - immunology
Variant Surface Glycoproteins, Trypanosoma
Title Effect of 3-aminobenzamide on antigenic variation of Trypanosoma brucei
URI https://www.ncbi.nlm.nih.gov/pubmed/2998400
Volume 34
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dSxwxEA_aUupLsVpRWyUPrSjn6n7lYx_L4QeFig8n-iZJNoETL3uch6B_vZNNbnc9LFVflpAsIezvt5OZSWYGoZ8GLK5SUhqlSQYGClFFJCUlkYYWESw3ZV2-7e8ZPb3I_1yRq9ahX0eXTOWBenwxruQ9qEIf4OqiZN-AbDMpdEAb8IUnIAzPV2EcUg-DvpdFYjS0ldT2ERql7tWXjKcu1eZQ9e7BIG5Uw8HkASRAdVeNRE86ZIfPDnaHroSWzyEwbtNaN473fjWx-tYd4tsgVhrI6kulPu9_x0NaTUJUSXtOL-yNJ8pl63NICk469zdmchTQLcgzORqckp4vadaRiqAkJC-Ka-85aGYDnZqTX26DTGPug386KI5HNYwwDEZp_N_BuTTaYWQRLTLu5OGZ8-qEHZtyGior-nXMQiwTetj07XKyF9a1hD6F2eZskVonGSyjL8GYwL89M76iBW1X0Of-rIbfCto59xA-7ONBG2h3t4938HkH3FV04qmEK4PnqYQrixsq4YZK7tUOlbCn0jd0cXw06J9GocZGpPKETaNUEs7AdGFcydhoKbQyNEuE5knOBOelZLEwLgUJzxQTIjW50TSLS6ELUDZ5uoY-2MrqdYRFZpSOY5MrMLu1FoIZkbLCFY43gmu5gdb8x7oe-0Qq1-Erbv5r4Dtaatn3A3008N_qLVACp3K7RvAJRBZYQw
link.rule.ids 783
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+3-aminobenzamide+on+antigenic+variation+of+Trypanosoma+brucei&rft.jtitle=Biochemical+pharmacology&rft.au=Cornelissen%2C+A+W&rft.au=Michels%2C+P+A&rft.au=Borst%2C+P&rft.au=Spanjer%2C+W&rft.date=1985-12-01&rft.issn=0006-2952&rft.volume=34&rft.issue=23&rft.spage=4151&rft_id=info:doi/10.1016%2F0006-2952%2885%2990208-4&rft_id=info%3Apmid%2F2998400&rft_id=info%3Apmid%2F2998400&rft.externalDocID=2998400
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-2952&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-2952&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-2952&client=summon